Tumor necrosis factor-α inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis

被引：32

作者：

Bosello, S ^{[1
]}

De Santis, M ^{[1
]}

Tolusso, B ^{[1
]}

Zoli, A ^{[1
]}

Ferraccioli, G ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy

来源：

ANNALS OF INTERNAL MEDICINE | 2005年 / 143卷 / 12期

关键词：

D O I：

10.7326/0003-4819-143-12-200512200-00019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：918 / 920

页数：3

共 6 条

[1]

Fabris M, 2002, J RHEUMATOL, V29, P1847

[2]

Gruschwitz MS, 1997, J RHEUMATOL, V24, P1936

[3] The coexistence of systemic sclerosis and rheumatoid arthritis in five patients - Clinical and immunogenetic features suggest a distinct entity [J].

Horiki, T ;

Moriuchi, J ;

Takaya, M ;

Uchiyama, M ;

Hoshina, Y ;

Inada, K ;

Inoko, H ;

Tsuji, K ;

Ichikawa, Y .

ARTHRITIS AND RHEUMATISM, 1996, 39 (01) :152-156

[4] Cytokine and chemokine levels in systemic sclerosis:: relationship with cutaneous and internal organ involvement [J].

Scala, E ;

Pallotta, S ;

Frezzolini, A ;

Abeni, D ;

Barbieri, C ;

Sampogna, F ;

De Pità, O ;

Puddu, P ;

Paganelli, R ;

Russo, G .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03) :540-546

[5]

Zimmermann C, 1998, ARTHRITIS RHEUM, V41, P1938, DOI 10.1002/1529-0131(199811)41:11<1938::AID-ART7>3.0.CO

[6]

2-X

← 1 →